Sign in

CIK 0002012593

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Rapport Therapeutics, Inc.

Sign in to watch
Ticker
RAPP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880724208
Phone
+1 857-321-8020
Business address
99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
Former names
Rapport Therapeutics, Inc.
Open-market buys, last 90 days
$22,023,904
in 7 filings
Open-market sales, last 90 days
$4,470,180
in 7 filings, $4.5M under 10b5-1 plans

Net +$17,553,724. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-22 PAUL STEVEN M Director Purchase +35,714 $27.28 $974K 77,380
2026-06-10 PAUL STEVEN M Director Grant or award · Stock Option (Right to Buy) +15,200 15,200
2025-09-12 PAUL STEVEN M Director Purchase +28,284 $24.50 $693K 28,284
2025-09-12 PAUL STEVEN M Director Purchase +13,382 $24.97 $334K 41,666
2025-06-17 PAUL STEVEN M Director Grant or award · Stock Option (Right to Buy) +21,850 21,850

Page 1 of 1 · 5 trades